Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

Landmark HIP trial shows risedronate reduces risk of hip fracture in elderly women with osteoporosis

Feb. 8, 2001

North American trial to evaluate Xenical in overweight adolescents

Feb. 8, 2001

Novel heterocyclic PKC inhibitors claimed for improving complications of diabetes

Feb. 7, 2001

BioStratum grants Pyridorin rights to Kowa for Japan and other Asian countries

Feb. 7, 2001

Pravastatin therapy associated with significant risk reduction for diabetes

Feb. 7, 2001

DuPont presents new serotonergic compounds for CNS and GI disorders

Feb. 6, 2001

Monoclonal antibodies against alphavbeta3 integrin designed at former Searle

Feb. 6, 2001

Formulation of glibenclamide with excellent percutaneous absorption

Feb. 6, 2001

Enzyme replacement therapy has potential to alleviate main symptoms of MPS-I

Feb. 6, 2001

Zarix licenses anticancer/antifungal agent from Chiron

Feb. 6, 2001

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 8, 2026.
New York University identifies new analogues of mannose-6-phosphate
BioWorld Science
New York University has discovered new analogues of mannose-6-phosphate reported to be potentially useful for the treatment of memory impairment,...
ASCO 2026: Chinese biopharma arrives at ASCO with pivotal wins
BioWorld
If the 2026 American Society of Clinical Oncology (ASCO) annual meeting in Chicago from May 30 to June 3 demonstrated anything about the evolution of China’s...
Bial-Portela discovers new OX1 receptor antagonists
BioWorld Science
Bial-Portela & Ca SA has patented new orexin OX1 receptor antagonists potentially useful for the treatment of anxiety disorders, depression, eating disorders,...
Autobahn on the fast track with bipolar thyroid agonist
BioWorld
Achieving high marks in the phase II Amplify-BD trial for bipolar I and II depression, Autobahn Therapeutics Inc.’s elunetirom, a brain-penetrant central nervous...